BiotechTube
Genetic Immunity

Genetic Immunity

Budapest, Hungary· Est.
geneticimmunity.hu
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $6.2M

Overview

Genetic Immunity is a private, pre-revenue biotech developing a proprietary plasmid DNA-based therapeutic vaccine platform. Its lead candidate, DermaVir®, is designed to boost cytotoxic T-cell responses to target and kill HIV-infected cells, positioning it as a potential functional cure component. The company leverages a multidisciplinary team and international collaborations, with core competencies spanning research, development, and GMP-compliant production planning for clinical batches in the EU.

Infectious DiseaseOncology

Technology Platform

Proprietary plasmid DNA-based therapeutic vaccine platform designed for transdermal delivery. It aims to stimulate antigen-specific cytotoxic T-lymphocyte (CTL) responses to treat existing viral infections and cancers.

Funding History

2
Total raised:$6.2M
Series A$5M
Grant$1.2M

Opportunities

The global need for a functional cure or improved therapy for HIV represents a multi-billion dollar market.
The adaptable plasmid DNA platform also offers expansion opportunities into large oncology and other infectious disease markets, such as HPV and Hepatitis B.

Risk Factors

High clinical development risk for its lead HIV candidate, given the historical challenges of therapeutic vaccines.
Significant financial risk as a pre-revenue company dependent on external funding.
Intense competition from large pharma and other biotechs in the HIV cure and immuno-oncology spaces.

Competitive Landscape

Genetic Immunity competes in the therapeutic HIV vaccine space against companies like AELIX Therapeutics and academic consortia. In the broader plasmid DNA/immunotherapy platform arena, it faces competition from larger firms like Inovio Pharmaceuticals and numerous biotechs developing mRNA and viral vector-based immunotherapies for cancer and infectious diseases.

More companies in Immunotherapy / Immuno-Oncology →More companies in Hungary →